MyD88 present in bone-marrow hematopoietic cells has been demonstrated to be neuroprotective in an animal model of amyotrophic lateral sclerosis [50], although bone-marrow-derived cells lacking MyD88 improve Alzheimer's disease-like pathology in two different mouse models of the disease [51]. Here, MYD88 is linked to amyotrophic lateral sclerosis.